HomeROQ • LON
add
Roquefort Therapeutics PLC
Previous close
GBX 3.80
Day range
GBX 4.30 - GBX 4.50
Year range
GBX 3.30 - GBX 9.50
Market cap
6.60M GBP
Avg Volume
1.85M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 331.10K | -41.78% |
Net income | -289.75K | 25.93% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -337.74K | 27.85% |
Effective tax rate | 17.54% | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 595.66K | -56.81% |
Total assets | 6.07M | -14.71% |
Total liabilities | 1.14M | 75.51% |
Total equity | 4.93M | — |
Shares outstanding | 129.15M | — |
Price to book | 0.95 | — |
Return on assets | -13.96% | — |
Return on capital | -15.30% | — |
Cash Flow
Net change in cash
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -289.75K | 25.93% |
Cash from operations | -262.26K | 40.97% |
Cash from investing | 97.00 | 100.36% |
Cash from financing | 292.46K | — |
Net change in cash | 29.17K | 106.18% |
Free cash flow | -204.12K | 35.56% |
About
Founded
2020
Website
Employees
10
